Clinical trial
Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer
NCT00388154 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00388154 |
|---|---|
| Title | Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer |
| Official title | A Phase II Study of Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Endometrial Cancer |
| Intervention type | Drug |
| Interventions | Gemcitabine, Cisplatin |
| Enrollment | 21 |
| Start date | Aug 1, 2004 |
| Primary completion | Nov 1, 2013 |
| Completion | Nov 1, 2013 |
| First posted | Oct 16, 2006 |
| Last update posted | Nov 13, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: